IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer

BACKGROUND: Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer (GC); however, the underlying mechanism remains unknown. METHODS: This study determined the expression of IRF-2 in GC tissues and adjacent non-tumor tissues using immunohistochemistry (IHC) and explored the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan-Jie, Luo, Shu-Neng, Wu, Hao, Zhang, Ning-Ping, Dong, Ling, Liu, Tao-Tao, Liang, Li, Shen, Xi-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812234/
https://www.ncbi.nlm.nih.gov/pubmed/35115027
http://dx.doi.org/10.1186/s12967-022-03275-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812234/
https://www.ncbi.nlm.nih.gov/pubmed/35115027
http://dx.doi.org/10.1186/s12967-022-03275-0

Ejemplares similares